Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ALACHUA, Fla., Aug. 5, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is...
-
ALACHUA, Fla., Aug. 4, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced record quarterly...
-
ALACHUA, Fla., July 15, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for...
-
ALACHUA, Fla., June 18, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the...
-
ALACHUA, Fla., June 16, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (Nasdaq:AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, announced...
-
ALACHUA, Fla., June 9, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (Nasdaq:AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled...
-
ALACHUA, Fla., June 4, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (Nasdaq:AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share...
-
ALACHUA, Fla., May 12, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, announced...